| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |